XML 55 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes
AB is a private partnership for federal income tax purposes and, accordingly, is not subject to federal or state corporate income taxes. However, AB is subject to a 4.0% New York City unincorporated business tax (“UBT”). Domestic corporate subsidiaries of AB, which are subject to federal, state and local income taxes, generally are included in the filing of a consolidated federal income tax return with separate state and local income tax returns being filed. Foreign corporate subsidiaries are generally subject to taxes in the jurisdictions where they are located.
In order to preserve AB’s status as a private partnership for federal income tax purposes, AB Units must not be considered publicly traded. The AB Partnership Agreement provides that all transfers of AB Units must be approved by AXA Equitable Life Insurance Company (a subsidiary of AXA, “AXA Equitable”) and the General Partner; AXA Equitable and the General Partner approve only those transfers permitted pursuant to one or more of the safe harbors contained in relevant treasury regulations. If AB Units were considered readily tradable, AB’s net income would be subject to federal and state corporate income tax, significantly reducing its quarterly distribution to AB Holding. Furthermore, should AB enter into a substantial new line of business, AB Holding, by virtue of its ownership of AB, would lose its status as a “grandfathered” publicly-traded partnership and would become subject to corporate income tax, which would reduce materially AB Holding’s net income and its quarterly distributions to AB Holding Unitholders.
Earnings before income taxes and income tax expense consist of:
 
Years Ended December 31,
 
2015
 
2014
 
2013
 
(in thousands)
Earnings before income taxes:
 
 
 
 
 
United States
$
520,282

 
$
493,311

 
$
471,813

Foreign
110,817

 
115,310

 
92,438

Total
$
631,099

 
$
608,621

 
$
564,251

Income tax expense:
 
 
 
 
 
Partnership UBT
$
6,855

 
$
9,356

 
$
4,403

Corporate subsidiaries:
 
 
 
 
 
Federal
2,576

 
6,321

 
7,032

State and local
539

 
1,326

 
2,318

Foreign
26,822

 
31,625

 
26,139

Current tax expense
36,792

 
48,628

 
39,892

Deferred tax (benefit)
1,330

 
(10,846
)
 
(3,063
)
Income tax expense
$
38,122

 
$
37,782

 
$
36,829


The principal reasons for the difference between the effective tax rates and the UBT statutory tax rate of 4.0% are as follows:
 
Years Ended December 31,
 
2015
 
2014
 
2013
 
(in thousands)
UBT statutory rate
$
25,244

 
4.0
 %
 
$
24,345

 
4.0
 %
 
$
22,570

 
4.0
 %
Corporate subsidiaries’ federal, state, local and foreign income taxes
25,720

 
4.1

 
24,516

 
4.0

 
27,766

 
4.9

Effect of ASC 740 adjustments, miscellaneous taxes, and other
2,643

 
0.4

 
2,586

 
0.4

 
(687
)
 
(0.1
)
Income not taxable resulting from use of UBT business apportionment factors
(15,485
)
 
(2.5
)
 
(13,665
)
 
(2.2
)
 
(12,820
)
 
(2.3
)
Income tax expense and effective tax rate
$
38,122

 
6.0

 
$
37,782

 
6.2

 
$
36,829

 
6.5


We recognize the effects of a tax position in the financial statements only if, as of the reporting date, it is “more likely than not” to be sustained based solely on its technical merits. In making this assessment, we assume that the taxing authority will examine the tax position and have full knowledge of all relevant information.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
 
Years Ended December 31,
 
2015
 
2014
 
2013
 
(in thousands)
Balance as of beginning of period
$
11,311

 
$
2,975

 
$
3,672

Additions for prior year tax positions

 
2,838

 

Reductions for prior year tax positions

 

 
(580
)
Additions for current year tax positions
693

 
5,498

 
706

Reductions for current year tax positions

 

 

Reductions related to closed years/settlements with tax authorities

 

 
(823
)
Balance as of end of period
$
12,004

 
$
11,311

 
$
2,975


The amount of unrecognized tax benefits as of December 31, 2015, 2014 and 2013, when recognized, is recorded as a reduction to income tax expense and reduces the company’s effective tax rate.
Interest and penalties, if any, relating to tax positions are recorded in income tax expense on the consolidated statements of income. The total amount of interest expense (credit) recorded in income tax expense during 2015, 2014 and 2013 was $0.4 million, $0.4 million and $0.1 million, respectively. The total amount of accrued interest payable recorded on the consolidated statements of financial condition as of December 31, 2015, 2014 and 2013 were $1.0 million, $0.6 million and $0.2 million, respectively. There were no accrued penalties as of December 31, 2015, 2014 or 2013.
Generally, the company is no longer subject to U.S. federal, state or local income tax examinations by tax authorities for any year prior to 2012, except as set forth below.
During the third quarter of 2014, the City of New York notified us of an examination of AB’s UBT returns for the years 2010 and 2011. The examination is ongoing.
Currently, there are no income tax examinations at our significant non-U.S. subsidiaries. Years that remain open and may be subject to examination vary under local law, and range from one to seven years.
At December 31, 2015, it is reasonably possible that $5.5 million of our unrecognized tax benefits will change within the next twelve months due to completion of tax authority exams.
Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The tax effect of significant items comprising the net deferred tax asset (liability) is as follows:
 
December 31,
 
2015
 
2014
 
(in thousands)
Deferred tax asset:
 
 
 
Differences between book and tax basis:
 
 
 
Benefits from net operating loss carryforwards
$
18,887

 
$
23,539

Long-term incentive compensation plans
17,092

 
18,694

Other, primarily accrued expenses deductible when paid
18,490

 
19,737

 
54,469

 
61,970

Less: valuation allowance
(13,709
)
 
(13,927
)
Deferred tax asset
40,760

 
48,043

Deferred tax liability:
 

 
 

Differences between book and tax basis:
 

 
 

Intangible assets
6,520

 
6,874

Investment in foreign subsidiaries
8,220

 
8,725

Other
766

 
1,900

Deferred tax liability
15,506

 
17,499

Net deferred tax asset
$
25,254

 
$
30,544


Valuation allowances of $13.7 million and $13.9 million were established as of December 31, 2015 and 2014, respectively, primarily due to the uncertainty of realizing certain net operating loss (“NOL”) carryforwards given the future losses expected to be incurred by the applicable subsidiaries. We had NOL carryforwards at December 31, 2015 of approximately $80.9 million in certain foreign locations with an indefinite expiration period and $135.7 million in certain domestic locations with expiration periods between 15 and 20 years. As of December 31, 2014, we had NOL carryforwards of approximately $86.9 million in certain foreign locations with an indefinite expiration period and $135.7 million in certain domestic locations with expiration periods between 15 and 20 years.
The deferred tax asset is included in other assets. Management has determined that realization of the net deferred tax asset is more likely than not based on anticipated future taxable income.
We provide income taxes on the undistributed earnings of non-U.S. corporate subsidiaries except to the extent that such earnings are permanently invested outside the United States. As of December 31, 2015, $892.0 million of accumulated undistributed earnings of non-U.S. corporate subsidiaries were permanently invested outside the U.S. At existing applicable income tax rates, additional taxes of approximately $74.8 million, net of foreign tax credits, would need to be provided if such earnings were remitted.